| 06/10/2026 3:14 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/28/2026 3:20 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 3:19 PM | Core Scientific (1839341) Subject JANE STREET GROUP, LLC (1595888) Filed by | Form SCHEDULE 13G | |
| 05/26/2026 3:02 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/20/2026 3:20 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/15/2026 6:46 PM | Core Scientific (1839341) Subject Valiant Capital Management, L.P. (1452689) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 3:49 PM | Citadel Securities GP LLC (1721695) Filed by Core Scientific (1839341) Subject | Form SCHEDULE 13G/A | |
| 05/15/2026 11:29 AM | Core Scientific (1839341) Subject SUSQUEHANNA SECURITIES, LLC (1446580) Filed by | Form SCHEDULE 13G/A | |
| 05/13/2026 3:06 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/11/2026 3:03 PM | Core Scientific (1839341) Issuer Ray Jorge L. (2123780) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 05/06/2026 3:54 PM | Core Scientific (1839341) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
Get the Latest News and Ratings for CORZW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Core Scientific and its competitors with MarketBeat's FREE daily newsletter.
|
| 05/06/2026 3:15 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/06/2026 3:02 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/06/2026 3:06 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/06/2026 6:52 AM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/29/2026 11:56 AM | Core Scientific (1839341) Subject VANGUARD PORTFOLIO MANAGEMENT LLC (2100121) Filed by | Form SCHEDULE 13G | |
| 04/27/2026 4:30 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/23/2026 7:59 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 04/22/2026 3:01 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/21/2026 6:36 AM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/17/2026 8:50 PM | Core Scientific (1839341) Issuer Sullivan Adam Taylor (1980208) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/17/2026 8:50 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/16/2026 7:35 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 04/15/2026 3:02 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/08/2026 3:32 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/02/2026 7:25 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/02/2026 7:26 PM | Core Scientific (1839341) Issuer Sullivan Adam Taylor (1980208) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/01/2026 3:44 PM | Core Scientific (1839341) Subject DUCHENE TODD M (1248745) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/31/2026 3:59 PM | Core Scientific (1839341) Filer | Form DEFA14A | |
| 03/31/2026 4:01 PM | Core Scientific (1839341) Filer | Form ARS | |
| 03/31/2026 3:55 PM | Core Scientific (1839341) Filer | Form DEF 14A | |
| 03/27/2026 5:45 PM | Core Scientific (1839341) Issuer Nygaard James P Jr (1842273) Reporting | Form 4/A | |
| 03/26/2026 4:39 PM | Core Scientific (1839341) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/23/2026 7:29 AM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/20/2026 7:39 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 03/19/2026 3:06 PM | Core Scientific (1839341) Issuer Nygaard James P Jr (1842273) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/18/2026 4:14 PM | Core Scientific (1839341) Filer | Form 10-K/A | |
| 03/12/2026 11:55 AM | Core Scientific (1839341) Subject Valiant Capital Management, L.P. (1452689) Filed by | Form SCHEDULE 13G | |
| 03/10/2026 3:08 PM | Core Scientific (1839341) Issuer Weiss Eric Stanton (2009491) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:13 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/04/2026 8:05 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
Goldman Sachs just told you what to buy (most people missed it) (Ad) Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - not chips, not funding, but power. Demand is growing 15% per year and the grid can't keep up.
One small company makes the exact equipment these data centers need. They're sitting on $1.5 billion in orders, their hardware is already inside Musk's Colossus, and the stock still trades like a name nobody's heard of. Analyst Dylan Jovine is releasing the ticker for free. See the stock positioned to solve AI's biggest power crisis |
| 03/02/2026 3:44 PM | Core Scientific (1839341) Filer | Form 10-Q/A | |
| 03/02/2026 3:18 PM | Core Scientific (1839341) Filer | Form 10-K/A | |
| 02/19/2026 8:17 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 02/19/2026 10:56 AM | Core Scientific (1839341) Filer | Form 8-K/A | |
| 02/18/2026 4:16 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/11/2026 10:11 AM | BARCLAYS PLC (312069) Filed by Core Scientific (1839341) Subject | Form SCHEDULE 13G/A | |
| 02/09/2026 5:08 PM | Core Scientific (1839341) Subject Valiant Capital Management, L.P. (1452689) Filed by | Form SCHEDULE 13G/A | |
| 02/06/2026 3:11 PM | Core Scientific (1839341) Issuer Weiss Eric Stanton (2009491) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 3:11 PM | Core Scientific (1839341) Issuer Rozov Yadin (1921268) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 3:11 PM | Core Scientific (1839341) Issuer CRAIN ELIZABETH (1604659) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 3:11 PM | Core Scientific (1839341) Issuer Levy Jordan (1541436) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 3:11 PM | Booth Jeffrey David (2009493) Reporting Core Scientific (1839341) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/26/2026 3:15 PM | Core Scientific (1839341) Issuer Sullivan Adam Taylor (1980208) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/20/2026 8:07 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 01/07/2026 1:59 PM | Core Scientific (1839341) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 01/02/2026 5:26 PM | Core Scientific (1839341) Issuer Rozov Yadin (1921268) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/18/2025 7:17 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 12/10/2025 5:12 PM | Citadel Securities GP LLC (1721695) Filed by Core Scientific (1839341) Subject | Form SCHEDULE 13G | |
| 12/01/2025 7:04 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 11/17/2025 5:35 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 11/13/2025 4:42 PM | Core Scientific (1839341) Subject SUSQUEHANNA SECURITIES, LLC (1446580) Filed by | Form SCHEDULE 13G/A | |
| 11/12/2025 3:05 PM | BARCLAYS PLC (312069) Filed by Core Scientific (1839341) Subject | Form SCHEDULE 13G | |
| 11/03/2025 5:42 PM | Core Scientific (1839341) Subject | Form SCHEDULE 13G | |
| 11/03/2025 5:42 PM | Core Scientific (1839341) Subject Valiant Capital Management, L.P. (1452689) Filed by Valiant Capital Management, L.P. (1452689) Filed by | Form SCHEDULE 13G | |
| 10/31/2025 4:16 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 10/31/2025 3:27 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/30/2025 3:18 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/30/2025 9:55 AM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/30/2025 9:28 AM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/28/2025 4:00 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form DFAN14A | |
| 10/24/2025 3:14 PM | Core Scientific (1839341) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 10/24/2025 3:06 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/22/2025 4:20 PM | Core Scientific (1839341) Subject CoreWeave, Inc. (1769628) Filed by | Form 425 | |
| 10/22/2025 3:44 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/22/2025 3:44 PM | Core Scientific (1839341) Subject | Form 425 | |
| 10/21/2025 4:22 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form DFAN14A | |
| 10/17/2025 4:00 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form DFAN14A | |
| 10/17/2025 5:09 AM | Core Scientific (1839341) Subject CoreWeave, Inc. (1769628) Filed by | Form 425 | |
| 10/16/2025 4:22 PM | Core Scientific (1839341) Subject CoreWeave, Inc. (1769628) Filed by | Form 425 | |
| 10/15/2025 3:45 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/15/2025 3:48 PM | Core Scientific (1839341) Subject | Form 425 | |
| 10/14/2025 4:50 PM | Core Scientific (1839341) Subject Situational Awareness LP (2045724) Filed by | Form SCHEDULE 13D/A | |
| 10/14/2025 7:30 AM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form DFAN14A | |
| 10/10/2025 7:48 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/10/2025 7:55 PM | Core Scientific (1839341) Subject | Form 425 | |
| 10/10/2025 4:27 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form DFAN14A | |
| 10/10/2025 4:02 PM | Core Scientific (1839341) Subject CoreWeave, Inc. (1769628) Filed by | Form 425 | |
| 10/09/2025 6:39 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 10/07/2025 4:27 PM | Core Scientific (1839341) Subject CoreWeave, Inc. (1769628) Filed by | Form 425 | |
| 10/07/2025 4:27 PM | Core Scientific (1839341) Subject CoreWeave, Inc. (1769628) Filed by | Form 425 | |
Trump Takes Emergency Action - Plus Elon Musk's New Venture (Ad) Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states.
The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now. See which companies control the supply chain behind this emerging tech |
| 10/07/2025 4:23 PM | Core Scientific (1839341) Subject CoreWeave, Inc. (1769628) Filed by | Form 425 | |
| 10/07/2025 4:24 PM | Core Scientific (1839341) Subject CoreWeave, Inc. (1769628) Filed by | Form 425 | |
| 09/29/2025 9:06 AM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form DFAN14A | |
| 09/29/2025 7:00 AM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form DEFC14A | |
| 09/26/2025 4:26 PM | Core Scientific (1839341) Filer | Form DEFM14A | |
| 08/14/2025 9:29 AM | Core Scientific (1839341) Subject SUSQUEHANNA SECURITIES, LLC (1446580) Filed by | Form SCHEDULE 13G | |
| 08/08/2025 8:40 AM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D | |
| 07/29/2025 10:21 AM | Core Scientific (1839341) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 07/16/2025 6:02 PM | BlackRock, Inc. (2012383) Filed by Core Scientific (1839341) Subject | Form SCHEDULE 13G/A | |